Sidoti Csr Analysts Increase Earnings Estimates for Balchem

Balchem Co. (NASDAQ:BCPC) – Analysts at Sidoti Csr raised their Q1 2025 earnings per share (EPS) estimates for Balchem in a report issued on Tuesday, February 25th. Sidoti Csr analyst D. Harriman now expects that the basic materials company will post earnings of $1.25 per share for the quarter, up from their previous estimate of $1.19. The consensus estimate for Balchem’s current full-year earnings is $4.64 per share. Sidoti Csr also issued estimates for Balchem’s Q2 2025 earnings at $1.28 EPS, Q3 2025 earnings at $1.30 EPS, Q4 2025 earnings at $1.27 EPS, FY2025 earnings at $5.10 EPS, Q1 2026 earnings at $1.33 EPS, Q2 2026 earnings at $1.36 EPS, Q3 2026 earnings at $1.38 EPS, Q4 2026 earnings at $1.33 EPS and FY2026 earnings at $5.40 EPS.

Several other equities analysts have also recently commented on the stock. StockNews.com cut shares of Balchem from a “buy” rating to a “hold” rating in a report on Tuesday. HC Wainwright reaffirmed a “buy” rating and issued a $190.00 target price on shares of Balchem in a research report on Monday.

Balchem Stock Up 4.8 %

Balchem stock opened at $173.59 on Wednesday. Balchem has a twelve month low of $137.69 and a twelve month high of $186.03. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.99. The firm has a market cap of $5.64 billion, a PE ratio of 44.17, a P/E/G ratio of 4.41 and a beta of 0.69. The firm’s 50 day moving average price is $162.01 and its two-hundred day moving average price is $169.44.

Balchem (NASDAQ:BCPC) last released its earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing the consensus estimate of $1.11 by ($0.08). The business had revenue of $240.00 million for the quarter, compared to analysts’ expectations of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%.

Balchem Increases Dividend

The firm also recently announced an annual dividend, which was paid on Friday, January 17th. Shareholders of record on Thursday, December 26th were given a $0.87 dividend. This represents a yield of 0.4%. This is an increase from Balchem’s previous annual dividend of $0.79. The ex-dividend date of this dividend was Thursday, December 26th. Balchem’s payout ratio is currently 22.14%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Westside Investment Management Inc. acquired a new position in Balchem during the third quarter worth $27,000. Covestor Ltd boosted its stake in shares of Balchem by 93.8% during the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company’s stock worth $26,000 after acquiring an additional 76 shares in the last quarter. R Squared Ltd acquired a new position in shares of Balchem during the 4th quarter valued at about $29,000. Wilmington Savings Fund Society FSB bought a new position in shares of Balchem in the 3rd quarter valued at approximately $35,000. Finally, Federated Hermes Inc. acquired a new stake in Balchem in the 4th quarter worth approximately $33,000. Institutional investors own 87.91% of the company’s stock.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.